Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

The influence of sodium salts (iodide, chloride and sulfate) on the formation efficiency of sulfamerazine nanocrystals.

Lou H, Liu M, Qu W, Johnson J, Brunson E, Almoazen H.

Pharm Dev Technol. 2014 Aug;19(5):548-55. doi: 10.3109/10837450.2013.805777. Epub 2013 Jun 13.

PMID:
23763457
2.

Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.

Li N, DeGennaro MD, Liebenberg W, Tiedt LR, Zahr AS, Pishko MV, de Villiers MM.

Pharmazie. 2006 Jul;61(7):595-603. Erratum in: Pharmazie. 2006 Aug;61(8):659. Zahn, AS [corrected to Zahr, AS].

PMID:
16889066
3.

Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs.

Niwa T, Danjo K.

Eur J Pharm Sci. 2013 Nov 20;50(3-4):272-81. doi: 10.1016/j.ejps.2013.07.011. Epub 2013 Jul 29.

PMID:
23907001
4.

Interactions of Na-salts and 1-propanol in 1-propanol-Na-Salt-H2O systems: toward an understanding the Hofmeister series (IV).

Miki K, Westh P, Koga Y.

J Phys Chem B. 2008 Apr 17;112(15):4680-6. doi: 10.1021/jp7113829. Epub 2008 Mar 25.

PMID:
18361525
5.

Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.

Monteiro A, Afolabi A, Bilgili E.

Drug Dev Ind Pharm. 2013 Feb;39(2):266-83. doi: 10.3109/03639045.2012.676048. Epub 2012 Apr 16.

PMID:
22503097
6.

Design, Optimization, and Evaluation of Lurasidone Hydrochloride Nanocrystals.

Shah S, Parmar B, Soniwala M, Chavda J.

AAPS PharmSciTech. 2016 Oct;17(5):1150-8. doi: 10.1208/s12249-015-0449-z. Epub 2015 Nov 19.

PMID:
26586537
7.

Nanoparticle formation of poorly water-soluble drugs from ternary ground mixtures with PVP and SDS.

Itoh K, Pongpeerapat A, Tozuka Y, Oguchi T, Yamamoto K.

Chem Pharm Bull (Tokyo). 2003 Feb;51(2):171-4.

8.

Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.

Zuo B, Sun Y, Li H, Liu X, Zhai Y, Sun J, He Z.

Int J Pharm. 2013 Oct 15;455(1-2):267-75. doi: 10.1016/j.ijpharm.2013.07.021. Epub 2013 Jul 20.

PMID:
23876497
9.

Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.

Salazar J, Müller RH, Möschwitzer JP.

Eur J Pharm Sci. 2013 Jul 16;49(4):565-77. doi: 10.1016/j.ejps.2013.04.003. Epub 2013 Apr 12.

PMID:
23587645
10.

Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating.

Hasegawa S, Furuyama N, Yada S, Hamaura T, Kusai A, Yonemochi E, Terada K.

Int J Pharm. 2007 May 4;336(1):82-9. Epub 2006 Nov 26.

PMID:
17178201
11.

The influence of co-formers on the dissolution rates of co-amorphous sulfamerazine/excipient systems.

Gniado K, Löbmann K, Rades T, Erxleben A.

Int J Pharm. 2016 May 17;504(1-2):20-6. doi: 10.1016/j.ijpharm.2016.03.023. Epub 2016 Mar 16.

PMID:
26992818
12.

Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.

Al-Obaidi H, Lawrence MJ, Shah S, Moghul H, Al-Saden N, Bari F.

Int J Pharm. 2013 Mar 25;446(1-2):100-5. doi: 10.1016/j.ijpharm.2013.02.009. Epub 2013 Feb 11.

PMID:
23410988
13.

Formation, physical stability and in vitro antimalarial activity of dihydroartemisinin nanosuspensions obtained by co-grinding method.

Chingunpitak J, Puttipipatkhachorn S, Chavalitshewinkoon-Petmitr P, Tozuka Y, Moribe K, Yamamoto K.

Drug Dev Ind Pharm. 2008 Mar;34(3):314-22. doi: 10.1080/03639040701662388 .

PMID:
18363147
14.

Development of a novel ultra cryo-milling technique for a poorly water-soluble drug using dry ice beads and liquid nitrogen.

Sugimoto S, Niwa T, Nakanishi Y, Danjo K.

Int J Pharm. 2012 Apr 15;426(1-2):162-9. doi: 10.1016/j.ijpharm.2012.01.007. Epub 2012 Jan 13.

PMID:
22266538
15.

Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.

Colombo M, Minussi C, Orthmann S, Staufenbiel S, Bodmeier R.

Eur J Pharm Biopharm. 2018 Jan 22. pii: S0939-6411(17)31381-4. doi: 10.1016/j.ejpb.2018.01.013. [Epub ahead of print]

PMID:
29371046
16.

Design and characterization of nanocrystal formulations containing ezetimibe.

Gulsun T, Gursoy RN, Oner L.

Chem Pharm Bull (Tokyo). 2011;59(1):41-5.

17.

Nanoparticle formation from probucol/PVP/sodium alkyl sulfate co-ground mixture.

Wanawongthai C, Pongpeerapat A, Higashi K, Tozuka Y, Moribe K, Yamamoto K.

Int J Pharm. 2009 Jul 6;376(1-2):169-75. doi: 10.1016/j.ijpharm.2009.04.034. Epub 2009 May 3.

PMID:
19409462
18.

Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture.

Pongpeerapat A, Wanawongthai C, Tozuka Y, Moribe K, Yamamoto K.

Int J Pharm. 2008 Mar 20;352(1-2):309-16. Epub 2007 Nov 9.

PMID:
18162340
19.

Investigation into physical-chemical variables affecting the manufacture and dissolution of wet-milled clarithromycin nanoparticles.

Shahbazi Niaz M, Traini D, Young PM, Ghadiri M, Rohanizadeh R.

Pharm Dev Technol. 2014 Dec;19(8):911-21. doi: 10.3109/10837450.2013.840844. Epub 2013 Oct 4.

PMID:
24093825
20.

Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.

Patterson JE, James MB, Forster AH, Lancaster RW, Butler JM, Rades T.

Int J Pharm. 2007 May 4;336(1):22-34. Epub 2006 Nov 15.

PMID:
17174493

Supplemental Content

Support Center